Clinical Trial

Early Feasibility Evaluation of the UniBE Hybrid Closed-loop Insulin Delivery System in Type 1 Diabetes: UBLoop-Genesis

Study acronym: UBLoop-Gen
Completed
View on ClinicalTrials.gov →
Summary
The study is investigating the early feasibility of a novel algorithm for a hybrid closed-loop (HCL) insulin delivery system in adult patients with Type 1 diabetes. Participants will attend a study visit where the UBLoop system on a smartphone will manage insulin delivery via an insulin pump, using blood glucose values from a continuous glucose meter. Specialized staff and a remote monitoring system, which is integrated into the UBLoop system, will oversee the participants.
Protocol Amendment History 5 changes
critical Trial completed 2026-07-17
notable Primary completion moved earlier: 2026-08-31 -> 2026-06-27 2026-07-17
minor Completion moved earlier: 2026-08-31 -> 2026-06-27 2026-07-17
notable Primary completion pushed: 2026-04-30 -> 2026-08-31 2026-07-01
minor Completion pushed: 2026-04-30 -> 2026-08-31 2026-07-01
Trial Details
NCT Number NCT07087340
Lead Sponsor University of Bern
Collaborators: DCB Research AG, DexCom, Inc., mylife Diabetes Care AG
Conditions Type-1-Diabetes
Enrollment 6 participants
Start Date 2026-01-21
Primary Completion 2026-06-27 (estimated)
Study Completion 2026-06-27 (estimated)
Updated on ClinicalTrials.gov 2026-07-16